“showed a trend”

The cell density within both depots, and of PPARγ-positive adipocytes (the most abundant cell type in BAT), showed a trend toward decrease in Hoxa5 null compared to wild-type embryos at E18.5 ( Figures 5A,B,F,G,K ).

The positive rate of bFGF showed a trend similar to that of HIF-1α (Fig. 4A, F ).

These results showed a trend that patients with lower plasma Elabela level had an exacerbated cardiac dysfunction than those with higher Elabela plasma level.

The results showed that, compared with no stimulation, patients' verbal fluency showed a trend of improvement at 10 Hz, but there was no statistical significance.

At the same time the drNPC group showed a trend toward better survival, however, the differences were not statistically significant.

The general condition of the patient showed a trend of improvement after abstinence, so we started treatment for HCC.

Interestingly, TAGs were not significantly increased, although TAGs composed of long (> C22) monounsaturated or diunsaturated fatty acids showed a trend of higher levels in aged mice (Fig. 2 B).

Although no statistical differences were found, Figure S5 showed a trend towards High Angio-High AP tumors as the earlier relapsing ones.

By contrast, body mass index (BMI) showed a trend to be a favorable marker of survival with a HR of 0.97 (CI95%: 0.926–1.01).

(n = 77), which showed a trend towards reduced risks of AD and food sensitization in infants at 6 and 12 months [ 52 ].

Our findings also showed a trend in genetic risk and glaucoma prevalence.

On the other hand, there are studies that showed a trend toward increased time to sputum conversion [ 1 , 12 , 63 , 65 ].

The significantly clustered genes showed a trend of gradual up- or down-regulation as one moved from controls to sepsis patients and then to septic shock patients.

Although, 32 of the 85 studies included in our review did not show a significant elevation in circulating CRP, some of these showed a trend of higher CRP, which did not reach statistical significance, possibly due to the small numbers included (type II error).

Furthermore, the amino acid concentrations showed a trend of enrichment in the NM group.

Interestingly, Pappa itself was slightly but significantly upregulated, and Igf2 showed a trend toward upregulation, suggesting a partial compensatory response.

Zeta potential measurements showed a trend in accordance with particle size; that is, the variations in the zeta potential of bare PLGA and PLGA-PVA NPs were more obvious than those of PLGA-PEG and PLGA-PDA NPs (Fig. 4d ), which confirmed that bare PLGA and PLGA-PVA NPs are more likely to bond with mucin.

In addition, one species showed a trend for receiving less interactions, one species for more interactions, respectively (Fig. 1a ).

In a follow-up study, we found that db/db mice treated by compound 10 showed a trend towards reduced food intake (12%) compared to those receiving vehicle treatment ( Figure 2 C), which likely contributed to the weight loss.

By contrast, AP‐21‐treated mice showed a trend of body weight loss in a dose‐dependent manner (Figure S8a, Supporting Information).

This correlated with the Western blotting data, which showed a trend of decreasing H3K9 as the pillar size/spacing increased, leading from a threefold reduction in total H3K9 in cells on the 1 × 5 micropillars to a fivefold decrease in cells on both the 5 × 5 and 10 × 5 designs (Figure 4g and Figure S8g, Supporting Information).

Although patients with no prior CPI showed a trend for more favorable progression-free survival relative to patients with prior CPI, the improvement in the 1-year OS did not reach the statistical threshold in this heavily treated patients.

Moreover, CRP elimination in STEMI through CRP apheresis showed a trend to improve, as further indication of effectiveness, myocardial perfusion by lowering microvascular obstruction (MVO).

However, restricted cubic spline analysis showed a trend of decreased probability of live-birth with increasing E2D.

QT prolongation) or showed a trend towards reversibility (e.g. skin, liver and hematopoietic toxic effects) upon entrectinib discontinuation.